Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

HIV Activist Winifred Ikilai: 5 Things to Know on World AIDS Day 2020

December 1, 2020

This World AIDS Day, 2020 AVAC Advocacy Fellow Winifred Ikilai shares her a community perspective on the need to ensure globally accessible tools to end the HIV epidemic.

Read more

In The News

Comet tails and a Trojan horse: One laboratory’s hunt for a COVID-19 vaccine

Los Angeles Times

November 13, 2020

Read more

Features

Study finds long-acting injectable HIV prevention option is effective for cisgender women

November 9, 2020

IAVI welcomes evidence of long-acting cabotegravir’s safety and efficacy in cisgender women.

Read more

Features

Participant Enrollment Begins for Phase 1 Trial of IAVI-Merck COVID-19 Vaccine Candidate

November 6, 2020

The study will assess the safety, tolerability, and immunogenicity of SARS-CoV-2 vaccine candidate V590 compared to placebo.

Read more

Scientific Publications

Prevalence and correlates of HIV infection among adolescents and young people living in fishing populations along Lake Victoria Fishing Communities in Uganda

Read more

Press Releases

IAVI Announces Start of Clinical Trial of Next-Generation HIV Vaccine Candidate

October 29, 2020

Aim is production of precursors to broadly neutralizing antibodies.

Read more

Press Releases

Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says

October 27, 2020

NEW YORK — OCTOBER 27, 2020 — IAVI announced today the award of US$26.7M from the Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) to support IAVI’s recombinant vesicular stomatitis virus (rVSV) vectored SARS-CoV-2 vaccine candidate. DTRA’s commitment will enable critical nonclinical development on the vaccine candidate that IAVI is developing…

Read more

Features

Progress Toward Global Access to Affordable Antibodies

October 23, 2020

There are more than 70 different mAbs in various stages of development for the treatment and prevention of COVID-19, including those discovered by a team of scientists including investigators from IAVI and Scripps Research.

Read more